HDHector F. DeLuca

Hector F. DeLuca

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hector F. DeLuca has a total of 194 co-authors. Here are the top co-authors by number of shared publications:

  • Lori A. Plum

    Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, United States

    41 shared publications
  • Margaret Clagett-Dame

    Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA

    15 shared publications
  • Rafal R. Sicinski

    Department of Chemistry, University of Warsaw, Pasteura 1, 02-093 Warsaw, Poland

    15 shared publications
  • Jean M. Prahl

    Department of Biochemistry, University of Wisconsin-Madison, 433 Babcock Drive, Madison, WI 53706-1544, United States

    9 shared publications
  • Pawel Grzywacz

    Department of Biochemistry, College of Agriculture and Life Sciences, University of Wisconsin-Madison, 433 Babcock Drive, Madison, WI 53706, USA

    8 shared publications
  • Claudia Zierold

    Department of Pathology and Laboratory Medicine, University of Wisconsin, 600 Highland Avenue, CSC K4/870-8550, Madison, WI 53792

    6 shared publications

Latest Publications

  • Open Access

    Consensus and Controversial Aspects of Vitamin D and COVID-19

    by John P Bilezikian, Neil Binkley, Hector F De Luca, Angelo Fassio, Anna Maria Formenti, Ghada El-Hajj Fuleihan, Annemieke C Heijboer, Andrea Giustina

    Objective: This work aims to review and discuss controversial topics in the field of vitamin D, SARS-CoV-2 infection, and COVID-19.Methods: The International Conferences “Controversies in Vitamin D” are a series of workshops that started in 2017 featuring international experts and leaders in vitamin D research and clinical practice. The fifth annual conference was held in Stresa, Italy, September 15 to 18, 2021.Evidence: Before the event, participants reviewed available studies on their assigned topic, drafted a related abstract, and presented their findings at the time of the conference. Relevant literature that became available since was also discussed within the panel and updated accordingly.Consensus: Before the event, the drafted abstracts had been merged to prepare a preliminary document. After the conference presentations, in-depth discussions in open sessions led to consensus. The document was subsequently modified according to discussions and up-to-date literature inclusion.Conclusions: There is quite consistent evidence for an association between low 25 OH vitamin D (25(OH)D) levels and poor COVID-19 outcomes, despite heterogeneous publications of variable quality. However, the low vitamin D status in COVID-19 patients might also reflect reverse causality. Vitamin D supplementation might have a positive role in COVID-19 prevention. The evidence supporting a beneficial effect of vitamin D treatment in decreasing the risk of COVID-19 complications is conflicting. Conclusive statements regarding the beneficial effect of vitamin D in this context await high-quality, randomized controlled trials.


  • Open Access

    Antibody production in mice requires neither vitamin D, nor the vitamin D receptor

    by Lori A. Plum, William Blaser, Logan Peter, Jean Prahl, Jeremy Seeman, Hector F. DeLuca

    The vitamin D receptor as well as its ligand have been localized to various immune tissues and cells. These observations have led researchers to hypothesize a role for vitamin D in the immune system. However, a specific role for vitamin D in immunity has yet to be clearly delineated. The work in this report was undertaken to determine if mounting an antibody response is altered in the face of vitamin D-deficiency or when the signaling pathway is eliminated by removal of the nuclear receptor. This investigation provides direct evidence vitamin D is not necessary for producing antibodies, a process paramount for optimal attack against many foreign organisms. The idea that vitamin D plays a significant role in immunity has been proposed repeatedly for many years. To address this important idea we have carried out studies in mice to determine if vitamin D plays a significant role in antibody production. Two animal models were utilized: mice depleted of vitamin D and mice devoid of the vitamin D receptor. Further, a possible role of hypocalcemia resulting from vitamin D deficiency in antibody production was determined. Neither the absence of vitamin D or the vitamin D receptor nor hypocalcemia affected the ability of mice to mount an antibody response to an antigen challenge. Thus, we found no evidence that vitamin D or normal serum calcium is required for this major form of immunity.


  • Open Access

    Vitamin D receptor absence does not enhance intestinal tumorigenesis in ApcPirc/+rats

    by Amy A. Irving, Bayley J. Waters, Jeremy R. Seeman, Lori A. Plum, Hector F. DeLuca

    Epidemiological observations have prompted some to posit that elevated circulating vitamin D is responsible for reduced colon cancer in individuals residing near the equator. We have previously demonstrated that vitamin D has no effect on colon cancer in two rodent models of intestinal tumorigenesis. We have now extended this line of inquiry to ask whether ablation of vitamin D receptor (VDR) affects tumorigenesis. A VDR null rat was developed using Cas9-CRISPR technology, which allowed us to investigate whether 1,25(OH)D3 signaling through its receptor plays a role in intestinal tumorigenesis. Loss of VDR expression alone did not induce tumorigenesis, even in animals exposed to the inflammatory agent dextran sodium sulfate. These VDR−/− rats were then crossed with ApcPirc/+ rats, which are predisposed to the development of intestinal neoplasms. In combination with the Pirc/+ mutation, VDR loss did not enhance tumor multiplicity, growth, or progression in the colon or small intestine. This study demonstrates that the vitamin D receptor does not impact tumor development, and strongly supports previous findings that vitamin D itself does not play a role in colon cancer development or progression. Alternative explanations are needed for the original latitude hypothesis, as well as observational data in humans. This article has an associated First Person interview with the first author of the paper.


  • Vitamin D esters are the major form of vitamin D produced by UV irradiation in mice

    by Elizabeth G. Duchow, Izabela K. Sibilska-Kaminski, Lori A. Plum, Hector F. DeLuca

    The primary source of vitamin D3 for humans is that produced in skin by ultraviolet irradiation. Ultraviolet (UV) B (UVB, 280–310 nm) light causes the isomerization of 7-dehydrocholesterol (7-DHC) to pre-vitamin D3 that is thermally isomerized to vitamin D3. In addition to free vitamin D3, it has been previously reported that esterified vitamin D3 is also found in the skin of rats irradiated with UVB. We found that a large fraction of the vitamin D3 precursor, 7-dehydrocholesterol is in the esterified form. Following UVB irradiation, vitamin D3 esters represent the majority of tissue vitamin D3, comprising approximately 80% in mice. Examination of vitamin D3 ester transport from skin in DBP−/− mice demonstrated that skin vitamin D3 ester content decreased only in the presence of DBP. No significant binding of vitamin D3 esters by serum was observed and no vitamin D3 esters were detectable in mouse serum after UVB treatment, indicating that the esters are hydrolyzed prior to transport into the circulation. The significance of vitamin D3 esters and their hydrolysis is the subject of current investigation. Graphical abstract


  • Novel superagonist analogs of 2-methylene calcitriol: Design, molecular docking, synthesis and biological evaluation

    by Izabela K. Sibilska-Kaminski, Adrian Fabisiak, Pawel Brzeminski, Lori A. Plum, Rafal R. Sicinski, Hector F. DeLuca


  • Open Access

    Vitamin D binding protein greatly improves bioactivity but is not essential for orally administered vitamin D

    by Elizabeth G. Duchow, Mark W. Duchow, Lori A. Plum, Hector F. DeLuca

    Vitamin D3 is a prohormone that is essential for calcium homeostasis. It is naturally produced in the skin by ultraviolet-B (UVB) irradiation of 7-dehydrocholesterol. In the absence of skin production, vitamin D3 can also be obtained from oral sources. However, the actual biological equivalence of naturally produced (i.e., UVB-irradiation of skin) and oral vitamin D3 has not been determined. We previously identified a unique and specific transport mechanism for skin-generated vitamin D3 which requires vitamin D binding protein (DBP); a mechanism that differs from absorption and transport of oral vitamin D3. In the following report, we examined the impact of this difference on the biological activity of vitamin D3. We report that UVB-generated vitamin D3 is more potent at raising serum calcium compared to oral vitamin D3, with the total biological activity being twofold higher. By examining the excretion of radiolabeled vitamin D3 injected unbound or pre-bound by DBP, we attributed the increased activity of skin-generated vitamin D3 to a significant reduction in biliary excretion of DBP-bound vitamin D relative to unbound vitamin D. Thus, removal of vitamin D3 from the skin by the natural DBP system markedly improves biological activity compared to that given orally.


  • Vitamin D

    by Lori A. Plum, Hector F. DeLuca

  • Vitamin D

    by Lori A. Plum, Hector F. DeLuca

  • Synthesis and Biological Activity of 2,22-Dimethylene Analogues of 19-Norcalcitriol and Related Compounds

    by Izabela K. Sibilska-Kaminski, Rafal R. Sicinski, Lori A. Plum, Hector F. DeLuca

    Continuing our search for vitamin D analogues, we explored the modification of the steroidal side chain and inserted a methylene moiety in position C-22 together with either lengthening the side chain or introducing a ring at the terminal end. Our conformational studies confirmed that the presence of a methylene group attached to C-22 restricts the conformational flexibility of the side chain, which can result in changes in biological characteristics of a molecule. All synthesized 1α,25-dihydroxy-2,22-dimethylene-19-norvitamin D3 analogues proved equal to calcitriol in their ability to bind to the vitamin D receptor, and most of them exert significantly higher differentiation and transcriptional activity than calcitriol. The most active compounds were characterized by the presence of an elongated side chain or 26,27-dimethylene bridge. The synthetic strategy was based on the Wittig–Horner coupling of the known A-ring phosphine oxide with the corresponding Grundmann ketones prepared from a 20-epi-Inhoffen-Lythgoe diol derived from vitamin D2.


  • Vitamin D binding protein is required to utilize skin-generated vitamin D

    by Elizabeth G. Duchow, Nancy E. Cooke, Jeremy Seeman, Lori A. Plum, Hector F. DeLuca

    Significance: The primary source of vitamin D in man is production in the skin following exposure to sunlight or artificially produced ultraviolet (UV) light. Despite the importance of this source, the mechanisms surrounding the transport of cutaneous vitamin D into the circulation have not been clearly defined. We have examined the vitamin D response to UVB in mutant mice lacking vitamin D binding protein (DBP). We have shown that in the absence of DBP, UVB does not correct vitamin D deficiency. Further, injection of small amounts of recombinant DBP to DBP −/− mice restores the response to vitamin D produced in skin. These results demonstrate a requirement for DBP in the utilization of vitamin D produced in the epidermis by UV light.